From this week on, RIVM will start releasing updates on vaccination coverage in the first groups to be vaccinated. The percentage of people who have been vaccinated against COVID-19 in the Netherlands is known for three groups of elderly people. At least the first COVID-19 jab has been given to 57% of people over 90 living at home, 61% of people aged 85-89, and 27% of people aged 80-84.
The figures were calculated based on the vaccinations administered up to 21 February. Within these three groups, there are still people who have already scheduled an appointment with the Municipal Public Health Services (GGDs) to get their first COVID-19 jab, so these percentages will continue to rise. Some of the people in these groups are not mobile enough to come to the GGD for a vaccination. They will be vaccinated later, most likely with the Moderna vaccine.
Weekly update on COVID-19 vaccination: 14 to 21 February 2021
The millionth vaccination against the coronavirus SARS-CoV-2 in the Netherlands was administered this past weekend. An estimated 795,300 people have received their first COVID-19 vaccination. More than 218,700 people are estimated to have received their second vaccination. With the current vaccines, a second vaccination is required for optimal protection against the coronavirus.
GP practices started vaccinations last week for the first people aged 60-64 and for some people who have a high risk of severe illness resulting from COVID-19. In this round, this concerns people with Down’s Syndrome and people with morbid obesity (BMI >40 kg/m2). These groups will be vaccinated with the AstraZeneca vaccine.
In the past week, the Netherlands received 193,050 doses of the Pfizer/BioNTech vaccine and 161,040 doses of the AstraZeneca vaccine.
AstraZeneca will deliver fewer vaccines than planned to the Netherlands (and the EU) this week and next (week 8 and week 9). As a result, no AstraZeneca vaccines will be distributed to vaccination sites in week 9. The more than 217,000 doses involved will be delivered later, and there will be an additional delivery of 211,000 doses in week 9 to compensate. More information is available here.